<?xml version="1.0" encoding="UTF-8"?>
<p>Therefore, based on the literature, the main goal of the present study was to evaluate whether PEL and LAT combination could be beneficial. We found that this novel combination, PEL+LAT, herein PELIRGOSTIM, had anti-inflammatory, antioxidant and antimicrobial activities, and that could be an alternative therapeutic strategy to the actual antimicrobial therapy.</p>
